BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aneesh A, Liu A, Moss HE, Feinstein D, Ravindran S, Mathew B, Roth S. Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 2021;12:594. [PMID: 34863294 DOI: 10.1186/s13287-021-02645-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ye C, Zhang Y, Su Z, Wu S, Li Y, Yi J, Lai W, Chen J, Zheng Y. hMSC exosomes as a novel treatment for female sensitive skin: An in vivo study. Front Bioeng Biotechnol 2022;10:1053679. [DOI: 10.3389/fbioe.2022.1053679] [Reference Citation Analysis]
2 Li DF, Yang MF, Xu J, Xu HM, Zhu MZ, Liang YJ, Zhang Y, Tian CM, Nie YQ, Shi RY, Wang LS, Yao J. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease. Int J Nanomedicine 2022;17:3893-911. [PMID: 36092245 DOI: 10.2147/IJN.S370784] [Reference Citation Analysis]
3 Ciapă MA, Șalaru DL, Stătescu C, Sascău RA, Bogdănici CM. Optic Neuritis in Multiple Sclerosis—A Review of Molecular Mechanisms Involved in the Degenerative Process. CIMB 2022;44:3959-3979. [DOI: 10.3390/cimb44090272] [Reference Citation Analysis]
4 Allegretta C, D'Amico E, Manuti V, Avolio C, Conese M. Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders. Int J Mol Sci 2022;23:3829. [PMID: 35409188 DOI: 10.3390/ijms23073829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Elshaer SL, Bahram SH, Rajashekar P, Gangaraju R, El-Remessy AB. Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases. Int J Mol Sci 2021;23:249. [PMID: 35008675 DOI: 10.3390/ijms23010249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]